Several studies have demonstrated that A-FABP, another important adipocytokine, is involved in the development of insulin resistance, inflammation and atherosclerosis, and the circulating A-FABP level is upregulated in patients with HF as well [27,28]. Here, FABP4 is linked to Insulin resistance.